Cavanaugh Stefanie L. 4
4 · Apollo Endosurgery, Inc. · Filed Mar 12, 2021
Insider Transaction Report
Form 4
Cavanaugh Stefanie L.
CFO, Treasurer, Secretary
Transactions
- Award
Common Stock
2021-03-10+14,028→ 95,907 total - Award
Stock Option (Right to Buy)
2021-03-10$5.95/sh+16,627$98,931→ 180,140 totalExercise: $5.95Exp: 2031-03-10→ Common Stock (16,627 underlying)
Footnotes (2)
- [F1]Represents the grant of Restricted Stock Units ("RSU"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock pursuant to the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan. The RSUs vest in equal annual installments over four years commencing on the grant date, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Incentive Plan.
- [F2]The shares underlying the option shall vest as to 25% on the first anniversary of the grant date and the remainder will vest in equal monthly installments over the following three years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan.